# Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel (MCAT)

> **NCT06504329** · NA · COMPLETED · sponsor: **Necmettin Erbakan University** · enrollment: 52 (actual)

## Conditions studied

- Gingival Recession

## Interventions

- **PROCEDURE:** Modified Coronally Advanced Tunnel (MCAT) + Subepithelial Connective Tissue Graft (SCTG)
- **PROCEDURE:** Modified Coronally Advanced Tunnel (MCAT) + Enamel Matrix Derivative (EMD)

## Key facts

- **NCT ID:** NCT06504329
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-24
- **Primary completion:** 2024-07-24
- **Final completion:** 2025-01-24
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06504329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06504329, "Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel (MCAT)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06504329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*